Federated Hermes
BLFS icon

Federated Hermes’s BioLife Solutions BLFS Stock Holding History

Federated Hermes’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.7K Buy
3,495
+493
+16% +$11.5K ﹤0.01% 1612
2026
Q1 		$57.3K Buy
+3,002
New +$66.4K ﹤0.01% 1668
2018
Q4 		– Sell
-36
Closed -$1K – 2201
2018
Q3 		$1K Sell
36
-277
-88% -$5.48K ﹤0.01% 2185
2018
Q2 		$4K Buy
+313
New +$2.85K ﹤0.01% 2035

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Federated Hermes's BLFS Position: Q2 2026 in Review

Federated Hermes increased its BioLife Solutions (BLFS) stake by 16% in Q2 2026, buying an estimated $11.5K and bringing the position to 3,495 shares worth $98.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

Federated Hermes first reported a position in BLFS in Q2 2018 and has held it in 4 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Federated Hermes held 3,495 shares of BioLife Solutions worth $98.7K as of Q2 2026.
  • Federated Hermes bought 493 BioLife Solutions shares in Q2 2026, an estimated $11.5K.
  • BioLife Solutions made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1612 holding.
  • Federated Hermes first reported a position in BioLife Solutions in Q2 2018 and has held it in 4 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.